From: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis
Treatment | Gender | Age | APACHE II scorea | SOFA scoreb |
---|---|---|---|---|
Placebo | 4 male 4 female | 54 – 68 years | 20.4 (15 – 29) | 13.3 ± 2.9 |
Lo-AscA | 5 male 3 female | 30 – 70 years | 20.4 (12 – 23) | 10.1 ± 2.0 |
Hi-AscA | 4 male 4 female | 49 – 92 years | 24.0 (12 – 33) | 10.8 ± 4.4 |